House Dems to begin considering drug pricing legislation next week

House Dems to begin considering drug pricing legislation next week
© Getty Images

House Democrats will begin considering legislation to lower drug prices at a hearing next week, moving forward on one of their top priorities, according to people familiar with the plan.

The House Energy and Commerce Committee will hold a legislative hearing on March 13 to consider bills to lower drug prices, the sources said.

ADVERTISEMENT

The measures are slated to be relatively smaller-scale bills that could get some bipartisan support, such as the Creates Act and “pay for delay” legislation, both of which aim to crack down on techniques drug companies use to delay the introduction of cheaper generic drugs.

Lowering drug prices is one of House Democrats' top priorities; Speaker Nancy PelosiNancy PelosiCummings to lie in state at the Capitol House Republicans 'demand the release of the rules' on impeachment Overnight Health Care — Presented by National Taxpayers Union —Dem wants more changes to Pelosi drug pricing bill | Ebola outbreak wanes, but funding lags | Johnson & Johnson recalls batch of baby powder after asbestos traces found MORE (D-Calif.) frequently touts drug prices as at the top of the agenda, along with infrastructure and fighting the influence of money in politics.

President TrumpDonald John TrumpFlorida GOP lawmaker says he's 'thinking' about impeachment Democrats introduce 'THUG Act' to block funding for G-7 at Trump resort Kurdish group PKK pens open letter rebuking Trump's comparison to ISIS MORE has also railed against the high cost of drugs, making the issue one of the rare areas where there could be some chance of bipartisan action.

The smaller-scale measures that Democrats will consider next week are part of a strategy to start with measures that are more likely to be bipartisan and get across the finish line before later moving on to bigger-ticket items like allowing Medicare to negotiate drug prices.

Still, any drug pricing measures always face a tough road, given the contentious nature of the issue and drug industry lobbying.

Committees in both the House and Senate have already held a slew of hearings on the issue of drug prices, but the Energy and Commerce hearing will be the first one this year to consider specific legislation.

In the Senate, Sen. Chuck GrassleyCharles (Chuck) Ernest GrassleyState cites 38 people for violations in Clinton email review Lawmakers from both sides of the aisle mourn Cummings GOP cautions Graham against hauling Biden before Senate MORE (R-Iowa), the chairman of the Finance Committee, also supports the Creates Act and “pay for delay” legislation, raising hopes that those bills could also get through the Senate, although that remains uncertain.